Exclusive Summary

• Methylprednisolone Tablets, an off-patent broad-spectrum corticosteroid, have a mature and stable global generic market.
• The product holds US FDA GMP certification and is registered in the US, signifying top-tier international quality standards for global market entry.
• Methylprednisolone is listed on the WHO Essential Medicines List and widely recommended by guidelines for various inflammatory and autoimmune diseases, ensuring solid clinical standing.
• As a generic drug, it offers a significant cost advantage over innovator drugs, aligning with global healthcare cost-reduction trends and promoting rapid market penetration.
• With FDA GMP certification, your company provides global partners with a cost-effective and compliant supply of Methylprednisolone Tablets.